![Agneta Svedberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Agneta Svedberg
Technik-/Wissenschafts-/F&E-Leiter bei
CAMURUS AB
Vermögen: 1 Mio $ am 31.05.2026
Profil
Agneta Svedberg is currently working as the VP-Clinical Development & Pharmacovigilance at Camurus AB since 2015.
Prior to this, she held positions as the Chief Executive Officer at Cantargia AB, Manager at Pharmacia & Upjohn, Inc., Principal at Oncotelic Therapeutics, Inc., Chief Operating Officer & Senior Vice President at Zealand Pharma A, and Senior Vice President-Clinical Development at Genmab, Inc. Ms. Svedberg has a graduate degree from the University of Lund and holds an MBA from Lund University School of Economics & Management and Executive Foundation Lund.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CAMURUS AB 0,04 % | 15.09.2025 | 22.987 ( 0,04 % ) | 1 Mio $ | 31.05.2026 |
Aktive Positionen von Agneta Svedberg
| Unternehmen | Position | Beginn |
|---|---|---|
| CAMURUS AB | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Agneta Svedberg
| Unternehmen | Position | Ende |
|---|---|---|
| CANTARGIA AB | Vorstandsvorsitzender | - |
| ZEALAND PHARMA A/S | Geschäftsführer | - |
| ONCOTELIC THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Pharmacia & Upjohn, Inc.
 Pharmacia & Upjohn, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical Preparations | Corporate Officer/Principal | - |
Genmab, Inc.
 Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Creates and develops human antibodies for the treatment of life-threatening and debilitating diseases | Corporate Officer/Principal | - |
Ausbildung von Agneta Svedberg
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
14
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Pharmacia & Upjohn, Inc.
Pharmacia & Upjohn, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical Preparations | Health Technology |
Oncotelic Therapeutics, Inc.
 Oncotelic Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing novel small-molecule therapeutics to treat cancer and eye diseases | Health Technology |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Camurus AB
 Camurus AB Pharmaceuticals: MajorHealth Technology Provides nanoscale drug delivery systems for development of high value therapeutics | Health Technology |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genmab, Inc.
Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Creates and develops human antibodies for the treatment of life-threatening and debilitating diseases | Commercial Services |
Cantargia AB
 Cantargia AB Pharmaceuticals: MajorHealth Technology Creates and develops antibody therapeutics for the treatment of leukemia | Health Technology |
Lund University School of Economics & Management
 Lund University School of Economics & Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Executive Foundation Lund
 Executive Foundation Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
